PEPFAR has helped millions, but 'hard work' lies ahead to sustain gains

PEPFAR, initiated in 2003, is "the largest global health initiative ever undertaken focused on a single disease," a Washington Post editorial writes, noting, "Now, after four years of work, some 400 interviews and visits to 13 nations, the Institute of Medicine of the National Academy of Sciences has provided [an] examination of this incredibly ambitious program." The editorial briefly recaps the findings of the report, which states "PEPFAR has been 'globally transformative,' a 'lifeline' and credited around the world for 'restoring hope' in the long, difficult struggle against HIV/AIDS, which has taken nearly 30 million lives over three decades."

"In the next decade, the challenge will be to sustain [the gains made in treatment, care and prevention], and much work remains," the Washington Post continues. "In the early years, PEPFAR's prevention programs were considered too narrow," the editorial writes, adding, "Now, the report notes, there has been a needed 'evolution' toward broader efforts." The editorial concludes, "Hard work is still ahead, and there may be fewer glowing report cards like this one. But Congress and the administration should take note: PEPFAR has changed millions of lives for the better and can do so in the next decade as well" (2/25).

http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Angiotensin receptor blockers found to lower epilepsy risk, new study reveals